Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

    Stock Recap
    #PipelineProspector

    Menu

    Risedronic Acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,046Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/11/2024 Polpharma
    Poland
    		 PHARMACEUTICAL WORKS POLPHARMA S.A. Starogard Gdanski PL R1-CEP 2013-126 - Rev 02 Risedronate sodium 2.5-hydrate 2022-05-09 Valid Chemical 2572
    28/11/2024 Aurobindo Pharma Limited
    India
    		 APITORIA PHARMA PRIVATE LIMITED Hyderabad IN CEP 2013-120 - Rev 02 Risedronate sodium 2.5-hydrate 2024-01-11 Valid Chemical 2572